@prefix ns2: . @prefix this: . @prefix sub: . @prefix schema: . @prefix np: . @prefix rdf: . @prefix nt: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix bl: . @prefix nkg: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "Xyrem is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy."; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:has_population_context sub:cohort; bl:provided_by "NeuroDKG"; bl:publications ; bl:relation nkg:SymptomaticReliefIndication . sub:cohort rdfs:label "patients 7 years of age and older"; schema:requiredMinAge "7"; bl:category bl:Cohort . bl:category bl:Drug . bl:category bl:Disease . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "Kq9J4mYkCLCzdhLyoq99+sYv27xcWpAhp1vuEriGshe69GhiHyYanzYrJIL+OYqucfA3kOEHLe2wSBA9EWqSElm31r1Hmvs6PITBVeoUT02DEkKHTZCrK7BubypgxdMcX1JPeC+oSSwKsEZqZ7AzqwlOkgJUVyoM4nCsoOz3DvI="; npx:hasSignatureTarget this: . this: ns2:created "2021-03-23T20:22:24.298+01:00"^^xsd:dateTime; ns2:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }